A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

Glaukos Investigative Site, Dothan, Alabama, United States

Glaukos Investigative Site, Petaluma, California, United States

Glaukos Investigative Site, Torrance, California, United States

Glaukos Investigative Site, Colorado Springs, Colorado, United States

Glaukos Investigative Site, Grand Junction, Colorado, United States

Glaukos Investigative Site, Bradenton, Florida, United States

Glaukos Investigative Site, Fort Myers, Florida, United States

Glaukos Investigative Site, South Miami, Florida, United States

Glaukos Investigative Site, Atlanta, Georgia, United States

Glaukos Investigative Site, Carmel, Indiana, United States

Glaukos Investigative Site, Fraser, Michigan, United States

Glaukos Investigative Site, Kansas City, Missouri, United States

Glaukos Investigative Site, Kansas City, Missouri, United States

Glaukos Investigative Site, Palisades Park, New Jersey, United States

Glaukos Investigative Site, Shelby, North Carolina, United States

Glaukos Investigative Site, Bala-Cynwyd, Pennsylvania, United States

Glaukos Investigative Site, Nashville, Tennessee, United States

Glaukos Investigative Site, Houston, Texas, United States

Glaukos Investigative Site, San Antonio, Texas, United States

Glaukos Investigative Site, Madison, Wisconsin, United States

Glaukos Investigative Site, Milwaukee, Wisconsin, United States

Glaukos Investigative Site, Mainz, Germany

Glaukos Investigative Site, München, Germany

Glaukos investigative Site, Messina, Italy

Glaukos Investigative Site, Barcelona, Spain

Glaukos Investigative Site, Madrid, Spain

Glaukos Investigative Site, Seville, Spain

Glaukos Investigative Site, Zaragoza, Spain